Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (12)

2024

  1. Analyzing Changes in Attitudes and Behaviors towards Seasonal Influenza Vaccination in Spain’s Adult Population over Three Seasons

    Vaccines, Vol. 12, Núm. 10

  2. Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain

    International Journal of Infectious Diseases, Vol. 143

  3. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

    Scientific Reports, Vol. 14, Núm. 1

  4. MiRNome Profiling of Extracellular Vesicles in Patients with Severe COVID-19 and Identification of Predictors of Mortality

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. 901-911

  5. Microbiological and epidemiological features of respiratory syncytial virus

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 209-220

  6. Potential Effects on Elderly People From Nirsevimab Use in Infants

    Open Respiratory Archives, Vol. 6, Núm. 2

2023

  1. Co-Existence of blaNDM-1, blaOXA-23, blaOXA-64, blaPER-7 and blaADC-57 in a Clinical Isolate of Acinetobacter baumannii from Alexandria, Egypt

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  3. Group 1 and group 2 hemagglutinin stalk antibody response according to age

    Frontiers in Immunology, Vol. 14

  4. Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults

    Human vaccines & immunotherapeutics, Vol. 19, Núm. 2, pp. 2236537

  5. The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population

    Vaccines, Vol. 11, Núm. 10

  6. The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control

    Journal of Medical Virology, Vol. 95, Núm. 11